A Silent Muscle Story: Clinical Insights from Amyopathic Dermatomyositis

Abstract

Amyopathic dermatomyositis (ADM) is a rare subset of dermatomyositis accounting for ~20% of dermatomyositis cases. The prevalence is higher in females and peaks in middle age. Diagnosis relies on hallmark skin manifestations such as heliotrope rash and Gottron’s papules, supported by skin biopsy, serologic markers (anti-MDA5, anti-TIF1γ), and imaging.
Unlike classic dermatomyositis, muscle enzymes and electromyography findings are typically normal. A 15-year-old female with no significant medical history presented with a one-month history of lowgrade fever and a progressive rash, along with oral ulcers for 15-days. The rash initially began as ill-defined macular to maculopapular lesions with fine scaling, predominantly involving sun-exposed areas, including the face (sparing the eyelids), ears, chin, anterior neck, and extensor surfaces of the arms, which extended later).
There is currently no specific randomized controlled trial that primarily involves ADM only. Further, treatment is often guided by the extent of cutaneous and systemic involvement. A better understanding may improve prognostication and therapeutic strategies, reducing morbidity and malignancy-associated mortality